MetaCap

AN2 Therapeutics Insider Trades

NASDAQ: ANTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.40-0.28 (-5.98%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $11.60K
Sales
12 · $344.53K
Shares bought / sold
2.10K / 59.44K
Net activity
Net selling $332,926

AN2 Therapeutics insider activity

Over the last 12 months, AN2 Therapeutics insiders reported 26 transactions on SEC Form 4: 1 open-market purchase and 12 sales. Insiders bought $11,602 and sold $344,528 worth of stock, for net insider selling of $332,926. The largest seller was Readnour Robin Shane, with $316,700 in reported sales.

The most recent filing shows Trenor Cameron C. III (Chief Medical Officer) reporting a transaction in 116,667 shares on Sep 15, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ANTX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ANTX insider transactions

AN2 Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 15, 2026Trenor Cameron C. IIIChief Medical OfficerAward116,667—Form 4
Sep 9, 2026Readnour Robin ShaneDirectorSale585$3.52KForm 4
Sep 9, 2026Readnour Robin ShaneDirectorSale523$3.15KForm 4
Sep 8, 2026Readnour Robin ShaneDirectorSale5,294$31.86KForm 4
Sep 8, 2026Readnour Robin ShaneDirectorSale4,725$28.44KForm 4
Sep 3, 2026Readnour Robin ShaneDirectorSale3,223$19.56KForm 4
Sep 3, 2026Readnour Robin ShaneDirectorSale2,877$17.46KForm 4
Sep 1, 2026FitzPatrick Margaret MDirectorBuy2,098$11.60KForm 4
Sep 1, 2026Williams Sarah JoannePrincipal Accounting OfficerSale272$1.50KForm 4
Aug 17, 2026Readnour Robin ShaneDirectorSale18,706$112.39KForm 4
Aug 17, 2026Readnour Robin ShaneDirectorSale16,696$100.31KForm 4
Aug 14, 2026Zakrzewski Joseph SDirectorGift405,880—Form 4
Jul 10, 2026Martin Patricia A.DirectorAward766—Form 4
Jul 10, 2026Marks Gilbert LynnDirectorAward2,789—Form 4
Jul 10, 2026Aziz KabeerDirectorAward2,852—Form 4
Jul 8, 2026Eizen Joshua MSee RemarksSale5,945$24.80KForm 4
May 29, 2026Williams Sarah JoannePrincipal Accounting OfficerSale265$1.17KForm 4
Apr 10, 2026Marks Gilbert LynnDirectorAward3,775—Form 4
Apr 10, 2026Martin Patricia A.DirectorAward1,192—Form 4
Apr 10, 2026Aziz KabeerDirectorAward3,775—Form 4
Mar 3, 2026Williams Sarah JoannePrincipal Accounting OfficerSale327$346.62Form 4
Feb 20, 2026Easom EricChief Executive OfficerAward112,250—Form 4
Feb 20, 2026Williams Sarah JoannePrincipal Accounting OfficerAward48,375—Form 4
Feb 20, 2026Eizen Joshua MSee RemarksAward50,000—Form 4
Feb 20, 2026Chanda SanjayChief Development OfficerAward38,000—Form 4
Feb 20, 2026Day LucyChief Financial OfficerAward38,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related